肥胖症患者体内的脂肪蛋白肽(adph 129-137)不是 cd8+ t 细胞的靶抗原。

IF 0.7 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM
Acta Endocrinologica-Bucharest Pub Date : 2024-01-01 Epub Date: 2024-10-03 DOI:10.4183/aeb.2024.21
M Asadipour, M R Ataollahi, K Shams, M Ali-Hassanzadeh, E Martinuzzi, K Kalantar
{"title":"肥胖症患者体内的脂肪蛋白肽(adph 129-137)不是 cd8+ t 细胞的靶抗原。","authors":"M Asadipour, M R Ataollahi, K Shams, M Ali-Hassanzadeh, E Martinuzzi, K Kalantar","doi":"10.4183/aeb.2024.21","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>In obesity, the infiltration of leukocytes into adipose tissue seems to play a key role in the development of inflammation and insulin resistance. Over-expression of adipophilin (ADPH) in adipose tissue, a protein which regulates lipid droplet structure and formation, has been reported in some studies.</p><p><strong>Objective: </strong>To investigate the role of ADPH 129-137 as a target for CD8+ T-cells in PBMCs of patients with obesity.</p><p><strong>Subjects and methods: </strong>PBMCs were obtained from 9 non-diabetic obese patients and 11 healthy subjects expressing the HLA-A0201 molecule. The ELISPOT assay used to monitor the presence of IFN-γ producing CD8+ T-cells against a HLA class I-restricted epitope derived from Adipophilin (ADPH 129-137) and two control peptides: Flu MP58-66 and Melan-A27-35.</p><p><strong>Results: </strong>The outcomes showed no significant difference between patient group and healthy donors in response to ADPH 129-137.</p><p><strong>Conclusion: </strong>These results demonstrated that ADPH 129-137 peptide possibly does not act as an autoantigen in patients with obesity.</p>","PeriodicalId":50902,"journal":{"name":"Acta Endocrinologica-Bucharest","volume":"20 1","pages":"21-26"},"PeriodicalIF":0.7000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11449246/pdf/","citationCount":"0","resultStr":"{\"title\":\"ADIPOPHILIN PEPTIDE (ADPH 129-137) IS NOT A TARGET ANTIGEN FOR CD8<sup>+</sup> T-CELLS IN PATIENTS WITH OBESITY.\",\"authors\":\"M Asadipour, M R Ataollahi, K Shams, M Ali-Hassanzadeh, E Martinuzzi, K Kalantar\",\"doi\":\"10.4183/aeb.2024.21\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Context: </strong>In obesity, the infiltration of leukocytes into adipose tissue seems to play a key role in the development of inflammation and insulin resistance. Over-expression of adipophilin (ADPH) in adipose tissue, a protein which regulates lipid droplet structure and formation, has been reported in some studies.</p><p><strong>Objective: </strong>To investigate the role of ADPH 129-137 as a target for CD8+ T-cells in PBMCs of patients with obesity.</p><p><strong>Subjects and methods: </strong>PBMCs were obtained from 9 non-diabetic obese patients and 11 healthy subjects expressing the HLA-A0201 molecule. The ELISPOT assay used to monitor the presence of IFN-γ producing CD8+ T-cells against a HLA class I-restricted epitope derived from Adipophilin (ADPH 129-137) and two control peptides: Flu MP58-66 and Melan-A27-35.</p><p><strong>Results: </strong>The outcomes showed no significant difference between patient group and healthy donors in response to ADPH 129-137.</p><p><strong>Conclusion: </strong>These results demonstrated that ADPH 129-137 peptide possibly does not act as an autoantigen in patients with obesity.</p>\",\"PeriodicalId\":50902,\"journal\":{\"name\":\"Acta Endocrinologica-Bucharest\",\"volume\":\"20 1\",\"pages\":\"21-26\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11449246/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Endocrinologica-Bucharest\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4183/aeb.2024.21\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/3 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Endocrinologica-Bucharest","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4183/aeb.2024.21","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/3 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

背景:在肥胖症中,白细胞渗入脂肪组织似乎在炎症和胰岛素抵抗的发展中起着关键作用。脂肪组织中的脂肪嗜蛋白(ADPH)是一种调节脂滴结构和形成的蛋白质,一些研究已报道了其过度表达的情况:目的:研究 ADPH 129-137 在肥胖症患者的 PBMC 中作为 CD8+ T 细胞靶点的作用:从 9 名非糖尿病肥胖患者和 11 名表达 HLA-A0201 分子的健康受试者中获取 PBMCs。ELISPOT 检测法用于监测产生 IFN-γ 的 CD8+ T 细胞是否存在,该检测法针对的是源自嗜脂肪蛋白(ADPH 129-137)的 HLA I 类限制性表位和两种对照肽:结果:结果显示,患者组和健康供体对 ADPH 129-137 的反应无明显差异:这些结果表明,ADPH 129-137 肽可能不会成为肥胖症患者的自身抗原。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
ADIPOPHILIN PEPTIDE (ADPH 129-137) IS NOT A TARGET ANTIGEN FOR CD8+ T-CELLS IN PATIENTS WITH OBESITY.

Context: In obesity, the infiltration of leukocytes into adipose tissue seems to play a key role in the development of inflammation and insulin resistance. Over-expression of adipophilin (ADPH) in adipose tissue, a protein which regulates lipid droplet structure and formation, has been reported in some studies.

Objective: To investigate the role of ADPH 129-137 as a target for CD8+ T-cells in PBMCs of patients with obesity.

Subjects and methods: PBMCs were obtained from 9 non-diabetic obese patients and 11 healthy subjects expressing the HLA-A0201 molecule. The ELISPOT assay used to monitor the presence of IFN-γ producing CD8+ T-cells against a HLA class I-restricted epitope derived from Adipophilin (ADPH 129-137) and two control peptides: Flu MP58-66 and Melan-A27-35.

Results: The outcomes showed no significant difference between patient group and healthy donors in response to ADPH 129-137.

Conclusion: These results demonstrated that ADPH 129-137 peptide possibly does not act as an autoantigen in patients with obesity.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Acta Endocrinologica-Bucharest
Acta Endocrinologica-Bucharest 医学-内分泌学与代谢
CiteScore
1.30
自引率
20.00%
发文量
53
审稿时长
6-12 weeks
期刊介绍: Acta Endocrinologica (Buc) is an international journal covering the fields of basic and clinical Endocrinology, Neuroendocrinology, Reproductive Medicine, Chronobiology, Human Ethology published quarterly Acta Endocrinologica (Buc) is the official international journal of the Romanian Society for Endocrinology. It continues the former Romanian Journal of Endocrinology
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信